These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17258725)

  • 1. Homozygous PMS2 deletion causes a severe colorectal cancer and multiple adenoma phenotype without extraintestinal cancer.
    Will O; Carvajal-Carmona LG; Gorman P; Howarth KM; Jones AM; Polanco-Echeverry GM; Chinaleong JA; Günther T; Silver A; Clark SK; Tomlinson I
    Gastroenterology; 2007 Feb; 132(2):527-30. PubMed ID: 17258725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exome sequencing in diagnostic evaluation of colorectal cancer predisposition in young patients.
    Tanskanen T; Gylfe AE; Katainen R; Taipale M; Renkonen-Sinisalo L; Mecklin JP; Järvinen H; Tuupanen S; Kilpivaara O; Vahteristo P; Aaltonen LA
    Scand J Gastroenterol; 2013 Jun; 48(6):672-8. PubMed ID: 23544471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paediatric intestinal cancer and polyposis due to bi-allelic PMS2 mutations: case series, review and follow-up guidelines.
    Herkert JC; Niessen RC; Olderode-Berends MJ; Veenstra-Knol HE; Vos YJ; van der Klift HM; Scheenstra R; Tops CM; Karrenbeld A; Peters FT; Hofstra RM; Kleibeuker JH; Sijmons RH
    Eur J Cancer; 2011 May; 47(7):965-82. PubMed ID: 21376568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gastrointestinal manifestation of constitutional mismatch repair deficiency syndrome: from a single adenoma to polyposis-like phenotype and early onset cancer.
    Levi Z; Kariv R; Barnes-Kedar I; Goldberg Y; Half E; Morgentern S; Eli B; Baris HN; Vilkin A; Belfer RG; Niv Y; Elhasid R; Dvir R; Abu-Freha N; Cohen S
    Clin Genet; 2015 Nov; 88(5):474-8. PubMed ID: 25307252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).
    Hendriks YM; Jagmohan-Changur S; van der Klift HM; Morreau H; van Puijenbroek M; Tops C; van Os T; Wagner A; Ausems MG; Gomez E; Breuning MH; Bröcker-Vriends AH; Vasen HF; Wijnen JT
    Gastroenterology; 2006 Feb; 130(2):312-22. PubMed ID: 16472587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A homozygous PMS2 founder mutation with an attenuated constitutional mismatch repair deficiency phenotype.
    Li L; Hamel N; Baker K; McGuffin MJ; Couillard M; Gologan A; Marcus VA; Chodirker B; Chudley A; Stefanovici C; Durandy A; Hegele RA; Feng BJ; Goldgar DE; Zhu J; De Rosa M; Gruber SB; Wimmer K; Young B; Chong G; Tischkowitz MD; Foulkes WD
    J Med Genet; 2015 May; 52(5):348-52. PubMed ID: 25691505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation.
    Gill S; Lindor NM; Burgart LJ; Smalley R; Leontovich O; French AJ; Goldberg RM; Sargent DJ; Jass JR; Hopper JL; Jenkins MA; Young J; Barker MA; Walsh MD; Ruszkiewicz AR; Thibodeau SN
    Clin Cancer Res; 2005 Sep; 11(18):6466-71. PubMed ID: 16166421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homozygous germ-line mutation of the PMS2 mismatch repair gene: a unique case report of constitutional mismatch repair deficiency (CMMRD).
    Ramchander NC; Ryan NA; Crosbie EJ; Evans DG
    BMC Med Genet; 2017 Apr; 18(1):40. PubMed ID: 28381238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G > T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue.
    van Puijenbroek M; Nielsen M; Tops CM; Halfwerk H; Vasen HF; Weiss MM; van Wezel T; Hes FJ; Morreau H
    Clin Cancer Res; 2008 Jan; 14(1):139-42. PubMed ID: 18172263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1.
    Krüger S; Kinzel M; Walldorf C; Gottschling S; Bier A; Tinschert S; von Stackelberg A; Henn W; Görgens H; Boue S; Kölble K; Büttner R; Schackert HK
    Eur J Hum Genet; 2008 Jan; 16(1):62-72. PubMed ID: 17851451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothesis: Possible role of retinoic acid therapy in patients with biallelic mismatch repair gene defects.
    Gottschling S; Reinhard H; Pagenstecher C; Krüger S; Raedle J; Plotz G; Henn W; Buettner R; Meyer S; Graf N
    Eur J Pediatr; 2008 Feb; 167(2):225-9. PubMed ID: 17387511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
    Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
    Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
    van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
    Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Café-au-lait macules and pediatric malignancy caused by biallelic mutations in the DNA mismatch repair (MMR) gene PMS2.
    Jackson CC; Holter S; Pollett A; Clendenning M; Chou S; Senter L; Ramphal R; Gallinger S; Boycott K
    Pediatr Blood Cancer; 2008 Jun; 50(6):1268-70. PubMed ID: 18273873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biallelic PMS2 mutations and a distinctive childhood cancer syndrome.
    Tan TY; Orme LM; Lynch E; Croxford MA; Dow C; Dewan PA; Lipton L
    J Pediatr Hematol Oncol; 2008 Mar; 30(3):254-7. PubMed ID: 18376293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer.
    Fallik D; Borrini F; Boige V; Viguier J; Jacob S; Miquel C; Sabourin JC; Ducreux M; Praz F
    Cancer Res; 2003 Sep; 63(18):5738-44. PubMed ID: 14522894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene.
    De Rosa M; Fasano C; Panariello L; Scarano MI; Belli G; Iannelli A; Ciciliano F; Izzo P
    Oncogene; 2000 Mar; 19(13):1719-23. PubMed ID: 10763829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing a clinical and molecular diagnosis for hereditary colorectal cancer syndromes: Present tense, future perfect?
    Jansen M; Menko FH; Brosens LA; Giardiello FM; Offerhaus GJ
    Gastrointest Endosc; 2014 Dec; 80(6):1145-55. PubMed ID: 25434663
    [No Abstract]   [Full Text] [Related]  

  • 19. Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors.
    Xicola RM; Llor X; Pons E; Castells A; Alenda C; Piñol V; Andreu M; Castellví-Bel S; Payá A; Jover R; Bessa X; Girós A; Duque JM; Nicolás-Pérez D; Garcia AM; Rigau J; Gassull MA;
    J Natl Cancer Inst; 2007 Feb; 99(3):244-52. PubMed ID: 17284719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutional Mismatch Repair Gene Defect Syndrome Presenting With Adenomatous Polyposis and Cafe au Lait Spots: A Case Report.
    Sağ E; Erkut M; Saygin İ; Çebi AH; Bahadir A; Erduran E; Saruhan H; Cakir M
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):e689-e691. PubMed ID: 31599855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.